Search Results - Philipp Reuken
- Showing 1 - 7 results of 7
-
1
-
2
-
3
Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical study by Sina M. Coldewey, Charles Neu, Frank Bloos, Philipp Baumbach, Ulrike Schumacher, Michael Bauer, Philipp Reuken, Andreas Stallmach
Published in Trials (2022-09-01)Get full text
Article -
4
Impact of different concurrent training sequencing schemes on overnight systemic immunological regulation in adolescent athletes by Thomas Steidten, Urs Granacher, Holger Gabriel, Simon Haunhorst, Simon Haunhorst, Philipp Reuken, Diana Dudziak, Christian Puta, Christian Puta, Christian Puta
Published in Frontiers in Physiology (2025-03-01)Get full text
Article -
5
From inflammation to degeneration – Enlarged perivascular spaces and glymphatic clearance in neuropsychiatric long-COVID syndrome by Bianca Besteher, Jussi Kantola, Meng Li, Jose Bernal, Marlene Machnik, Philipp Reuken, Kathrin Finke, Nils Opel, Vesa Kiviniemi, Hendrik Mattern, Martin Walter
Published in Journal of Affective Disorders Reports (2023-04-01)Get full text
Article -
6
Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors by Valeska Kozik, Philipp Reuken, Isabelle Utech, Judith Gramlich, Zoe Stallmach, Nele Demeyere, Florian Rakers, Matthias Schwab, Andreas Stallmach, Andreas Stallmach, Kathrin Finke, Kathrin Finke
Published in Frontiers in Psychology (2023-10-01)Get full text
Article -
7
P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERINFLAMMATION: THE RUXCOFLAM TRIAL by Sebastian Birndt, Jakob Hammersen, Konstanze Döhner, Philipp Reuken, Paul Sauerbrey, Felicitas La Rosée, Markus Pfirrmann, Christian Fabisch, Gerald Illerhaus, Manfred Weiß, Karl Träger, Hinrich Bremer, Daniel Drömann, Sylke Schneider, Paul La Rosee, Andreas Hochhaus
Published in HemaSphere (2023-08-01)Get full text
Article
